HP
28
-12
F
56
2
CCL
57
6
AA
56
8
DFS
42
-18
DLTR
43
3
ADP
69
3
DNB
60
2
KMI
81
6
EMR
60
4
DG
40
2
LB
64
2
BAC
65
2
CVS
64
2
K
59
3
DRI
66
2
DE
62
2
ACN
33
4
CAG
55
2
L
56
-6
HP
28
-12
F
56
2
CCL
57
6
AA
56
8
DFS
42
-18
DLTR
43
3
ADP
69
3
DNB
60
2
KMI
81
6
EMR
60
4
DG
40
2
LB
64
2
BAC
65
2
CVS
64
2
K
59
3
DRI
66
2
DE
62
2
ACN
33
4
CAG
55
2
L
56
-6
Financhill
Back

Bicara Therapeutics Vs. Strategy Industry Stock Comparison

Buy
55

BCAX
Bicara Therapeutics

Last Price:
$13.48
Seasonality Move:
--
Buy
52

MSTR
Strategy

Last Price:
$294.14
Seasonality Move:
-5.49%
Buy
55
Bicara Therapeutics (BCAX) is a Buy

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $13.50. The Score for BCAX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Strategy (MSTR) is a Buy

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $294.27. The Score for MSTR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MSTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $13.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $294.27
    The current trend is relatively stagnant and MSTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 49.06 Sell
Chaikin Money Flow: 387051 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.34 - 14.42) Buy
Bollinger Bands (100): (12.93 - 21.21) Sell

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.38 Sell
Relative Strength Index (14 RSI): 50.53 Buy
Chaikin Money Flow: 8661825 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (264.27 - 326.63) Sell
Bollinger Bands (100): (266.3 - 382.96) Sell

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.25 Sell
20-day SMA: 13.52 Sell
50-day SMA: 13.44 Buy
200-day SMA: 0 Buy
8-day EMA: 13.61 Sell
20-day EMA: 13.57 Sell
50-day EMA: 14.04 Sell
200-day EMA: 11.16 Buy

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 284.75 Buy
20-day SMA: 287.61 Buy
50-day SMA: 320.37 Sell
200-day SMA: 237.74 Buy
8-day EMA: 282.26 Buy
20-day EMA: 290.16 Buy
50-day EMA: 308.43 Sell
200-day EMA: 252.4 Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):